Literature DB >> 21274972

Left ventricular diastolic function assessment from three-dimensional three-directional velocity-encoded MRI with retrospective valve tracking.

Anne Brandts1, Matteo Bertini, Evert-Jan van Dijk, Victoria Delgado, Nina Ajmone Marsan, Rob J van der Geest, Hans-Marc J Siebelink, Albert de Roos, Jeroen J Bax, Jos J M Westenberg.   

Abstract

PURPOSE: To compare parameters describing left ventricular (LV) diastolic function obtained with three-dimensional (3D) three-directional velocity-encoded (VE) MRI with retrospective valve tracking and two-dimensional (2D) one-directional VE MRI in patients with ischemic heart failure. Second, to compare classification of LV diastolic function, and in particular for discriminating restrictive filling patterns, with both MRI techniques versus Doppler echocardiography.
MATERIALS AND METHODS: The 3D and 2D VE MRI early (E) and atrial (A) peak flow rate indices, determined from transmitral waveform analyses, were compared. Also, net forward flow volume per cycle and transmitral regurgitation fraction were determined. Agreement in classifying diastolic filling patterns between 3D and 2D VE MRI versus Doppler echocardiography was evaluated using kappa statistics.
RESULTS: The 3D three-directional VE MRI with retrospective valve tracking was statistically significantly different from 2D one-directional VE MRI for net forward flow volume and regurgitation fraction through the mitral valve and all parameters describing the diastolic waveform filling pattern, except for the E deceleration time and E/A filling ratio. Kappa-agreement between 3D three-directional VE MRI with retrospective valve tracking and echocardiography for classifying diastolic filling patterns was superior to 2D one-directional VE MRI and echocardiography (i.e., κ = 0.91 versus κ = 0.79, respectively).
CONCLUSION: The 3D three-directional VE MRI with retrospective valve tracking better describes LV diastolic function as compared to 2D one-directional VE MRI in patients with ischemic heart failure.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21274972     DOI: 10.1002/jmri.22424

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

Review 1.  Cardiotoxicity due to chemotherapy: role of cardiac imaging.

Authors:  Frédéric Poulin; Paaladinesh Thavendiranathan
Journal:  Curr Cardiol Rep       Date:  2015-03       Impact factor: 2.931

2.  Age-specific changes in left ventricular diastolic function: a velocity-encoded magnetic resonance imaging study.

Authors:  Golmehr Ashrafpoor; Emilie Bollache; Alban Redheuil; Alain De Cesare; Alain Giron; Carine Defrance; Arshid Azarine; Ludivine Perdrix; Magalie Ladouceur; Benoît Diebold; Elie Mousseaux; Nadjia Kachenoura
Journal:  Eur Radiol       Date:  2014-11-28       Impact factor: 5.315

3.  Fully automated intracardiac 4D flow MRI post-processing using deep learning for biventricular segmentation.

Authors:  Philip A Corrado; Andrew L Wentland; Jitka Starekova; Archana Dhyani; Kara N Goss; Oliver Wieben
Journal:  Eur Radiol       Date:  2022-02-17       Impact factor: 7.034

4.  A Systematic Review of 4D-Flow MRI Derived Mitral Regurgitation Quantification Methods.

Authors:  Benjamin Fidock; Natasha Barker; Nithin Balasubramanian; Gareth Archer; Graham Fent; Abdullah Al-Mohammad; James Richardson; Laurence O'Toole; Norman Briffa; Alexander Rothman; Rob van der Geest; Rod Hose; James M Wild; Andrew J Swift; Pankaj Garg
Journal:  Front Cardiovasc Med       Date:  2019-08-02

5.  Quantification and visualization of cardiovascular 4D velocity mapping accelerated with parallel imaging or k-t BLAST: head to head comparison and validation at 1.5 T and 3 T.

Authors:  Marcus Carlsson; Johannes Töger; Mikael Kanski; Karin Markenroth Bloch; Freddy Ståhlberg; Einar Heiberg; Håkan Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2011-10-04       Impact factor: 5.364

Review 6.  Unravelling cardiovascular disease using four dimensional flow cardiovascular magnetic resonance.

Authors:  Vivian P Kamphuis; Jos J M Westenberg; Roel L F van der Palen; Nico A Blom; Albert de Roos; Rob van der Geest; Mohammed S M Elbaz; Arno A W Roest
Journal:  Int J Cardiovasc Imaging       Date:  2016-11-25       Impact factor: 2.357

Review 7.  The Emerging Role of Cardiac Magnetic Resonance Imaging in the Evaluation of Patients with HFpEF.

Authors:  Jessica Webb; Lauren Fovargue; Kristin Tøndel; Bradley Porter; Benjamin Sieniewicz; Justin Gould; Christopher Aldo Rinaldi; Tevfik Ismail; Amedeo Chiribiri; Gerald Carr-White
Journal:  Curr Heart Fail Rep       Date:  2018-02

8.  Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease.

Authors:  Sohrab Fratz; Taylor Chung; Gerald F Greil; Margaret M Samyn; Andrew M Taylor; Emanuela R Valsangiacomo Buechel; Shi-Joon Yoo; Andrew J Powell
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-13       Impact factor: 5.364

9.  Cardiovascular magnetic resonance evaluation of left ventricular peak filling rate using steady-state free precession and phase contrast sequences.

Authors:  Shotaro Komi; Yusuke Inoue; Hirofumi Hata; Ai Nakajima; Hiroki Miyatake
Journal:  Springerplus       Date:  2016-07-25

10.  Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.

Authors:  Huub J van Eyk; Linda D van Schinkel; Vasudev Kantae; Charlotte E A Dronkers; Jos J M Westenberg; Albert de Roos; Hildo J Lamb; J Wouter Jukema; Amy C Harms; Thomas Hankemeier; Mario van der Stelt; Ingrid M Jazet; Patrick C N Rensen; Johannes W A Smit
Journal:  Nutr Diabetes       Date:  2018-01-17       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.